{
  "experiment_id": "342b067dbb5e342c2084a2145b36b155",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "9dc5c284f909400a12e111d9ec8ba4e5",
  "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
  "system_instructions": "_No response_",
  "temperature": 0.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-12-11T04:53:25.642953",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"Neurofibromatosis\". The Target Schema provides specific types of neurofibromatosis such as \"Neurofibromatosis type 1\". Since \"Neurofibromatosis\" is broad and could refer to different types, we need to choose the most specific one available in the schema. \"Neurofibromatosis type 1\" is a specific type, so we'll use that.\n\n2. **Assay**: The input value is \"DNA sequencing\". The Target Schema has several specific DNA sequencing techniques like \"Sanger sequencing\", \"whole exome sequencing\", \"whole genome sequencing\", etc. \"DNA sequencing\" is broad and could refer to any of these. The most specific match in the schema for \"DNA sequencing\" could be considered as \"Sanger sequencing\" if it's traditional sequencing, or other more specific types if the context is known. Without more context, \"Sanger sequencing\" is a reasonable choice for traditional DNA sequencing.\n\n3. **TumorType**: The input value is \"Neurofibroma\". The Target Schema lists various types of neurofibromas such as \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Plexiform Neurofibroma\", etc. \"Neurofibroma\" is a broad term that could refer to any of these. We need to choose a more specific type. Since the exact type isn't specified, we'll choose one of the specific types listed in the schema.\n\nLet's correct the metadata:\n\n- For \"diagnosis\", we'll use \"Neurofibromatosis type 1\" as it's a specific type listed in the schema.\n- For \"assay\", we'll use \"Sanger sequencing\" as a specific type of DNA sequencing.\n- For \"tumorType\", we'll use \"Plexiform Neurofibroma\" as a specific type of neurofibroma.\n\nCorrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"Sanger sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\nThis correction narrows down the broad terms to more specific ones as per the Target Schema. Note that the exact correction for \"tumorType\" could vary based on the specific context or type of neurofibroma being referred to.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2304,
            "outputTokens": 492,
            "totalTokens": 2796
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "11171b81-6919-4b96-83cd-89e9b2018359",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:07 GMT",
                "content-type": "application/json",
                "content-length": "2424",
                "connection": "keep-alive",
                "x-amzn-requestid": "11171b81-6919-4b96-83cd-89e9b2018359"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"Neurofibromatosis\". The Target Schema provides specific types of neurofibromatosis such as \"Neurofibromatosis type 1\". Since \"Neurofibromatosis\" is broad and could refer to different types, we need to choose the most specific one available in the schema. \"Neurofibromatosis type 1\" is a specific type, so we'll use that.\n\n2. **Assay**: The input value is \"DNA sequencing\". The Target Schema has several specific DNA sequencing techniques like \"Sanger sequencing\", \"whole exome sequencing\", \"whole genome sequencing\", etc. \"DNA sequencing\" is broad and could refer to any of these. The most specific match in the schema for \"DNA sequencing\" could be considered as \"Sanger sequencing\" if it's traditional sequencing, or other more specific types if the context is known. Without more context, \"Sanger sequencing\" is a reasonable choice for traditional DNA sequencing.\n\n3. **TumorType**: The input value is \"Neurofibroma\". The Target Schema lists various types of neurofibromas such as \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Plexiform Neurofibroma\", etc. \"Neurofibroma\" is a broad term that could refer to any of these. We need to choose a more specific type. Since the exact type isn't specified, we'll choose one of the specific types listed in the schema.\n\nLet's correct the metadata:\n\n- For \"diagnosis\", we'll use \"Neurofibromatosis type 1\" as it's a specific type listed in the schema.\n- For \"assay\", we'll use \"Sanger sequencing\" as a specific type of DNA sequencing.\n- For \"tumorType\", we'll use \"Plexiform Neurofibroma\" as a specific type of neurofibroma.\n\nCorrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"Sanger sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\nThis correction narrows down the broad terms to more specific ones as per the Target Schema. Note that the exact correction for \"tumorType\" could vary based on the specific context or type of neurofibroma being referred to."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2304,
              "outputTokens": 492,
              "totalTokens": 2796
            },
            "metrics": {
              "latencyMs": 2661
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2304,
          "output_tokens": 492,
          "total_tokens": 2796
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the value is \"NF\". \"NF\" is a broad term that could refer to Neurofibromatosis. The Target Schema provides specific types of neurofibromatosis and related conditions. The most specific match for \"NF\" in the given context could be \"Neurofibromatosis type 1\".\n\n2. For the \"assay\" field, the value is \"exome sequencing\". The Target Schema has an enum value \"whole exome sequencing\" which is a more specific term for \"exome sequencing\".\n\n3. For the \"tumorType\" field, the value is \"sarcoma\". The Target Schema includes \"Sarcoma\" as an enum value, so no change is needed here as it directly matches one of the allowed values.\n\nHere is the corrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```\n\nThis correction ensures that the metadata values are as specific as possible and adhere to the controlled terminology defined in the Target Schema.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2301,
            "outputTokens": 257,
            "totalTokens": 2558
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "b9e502a2-7189-4427-9f85-4fbd953f47e8",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:08 GMT",
                "content-type": "application/json",
                "content-length": "1360",
                "connection": "keep-alive",
                "x-amzn-requestid": "b9e502a2-7189-4427-9f85-4fbd953f47e8"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the value is \"NF\". \"NF\" is a broad term that could refer to Neurofibromatosis. The Target Schema provides specific types of neurofibromatosis and related conditions. The most specific match for \"NF\" in the given context could be \"Neurofibromatosis type 1\".\n\n2. For the \"assay\" field, the value is \"exome sequencing\". The Target Schema has an enum value \"whole exome sequencing\" which is a more specific term for \"exome sequencing\".\n\n3. For the \"tumorType\" field, the value is \"sarcoma\". The Target Schema includes \"Sarcoma\" as an enum value, so no change is needed here as it directly matches one of the allowed values.\n\nHere is the corrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```\n\nThis correction ensures that the metadata values are as specific as possible and adhere to the controlled terminology defined in the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2301,
              "outputTokens": 257,
              "totalTokens": 2558
            },
            "metrics": {
              "latencyMs": 1402
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2301,
          "output_tokens": 257,
          "total_tokens": 2558
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"Neurofibromatoses\". Looking at the Target Schema for \"diagnosis\", the closest and most specific term related to \"Neurofibromatoses\" is \"Neurofibromatosis type 1\". This is because \"Neurofibromatoses\" typically refers to a group of disorders that include Neurofibromatosis type 1, Neurofibromatosis type 2, and Schwannomatosis. Since \"Neurofibromatosis type 1\" is the most common condition associated with the term \"Neurofibromatoses\", we will use this as our corrected value.\n\n2. **Assay**: The input value is \"assay by high throughput sequencer\". The Target Schema for \"assay\" includes several sequencing-related terms. \"High throughput sequencer\" is commonly associated with \"next generation sequencing\" techniques. Among the options provided, \"whole exome sequencing\", \"whole genome sequencing\", and \"targeted sequencing\" are all forms of next-generation sequencing. However, without more specificity, the most general form that could be considered is \"next generation targeted sequencing\". This term is available in the enum list.\n\n3. **TumorType**: The input value is \"Nerve Sheath Neoplasm\". The Target Schema for \"tumorType\" includes several specific types of nerve sheath tumors. \"Nerve Sheath Neoplasm\" can refer to various types, including Schwannoma, Neurofibroma, and Malignant Peripheral Nerve Sheath Tumor. Among these, \"Neurofibroma\" and \"Schwannoma\" are directly listed. \"Malignant Peripheral Nerve Sheath Tumor\" is also listed. Without more specific information, we can choose one of these. \"Neurofibroma\" is a reasonable choice given its frequency and relevance.\n\nCorrected metadata:\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"next generation targeted sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nHowever, it's worth noting that \"next generation targeted sequencing\" is the chosen value for \"assay\" here because it's a specific term available in the enum. If the exact type of sequencing is known (e.g., whole exome, whole genome), that would be more appropriate. \n\nAlso, for \"tumorType\", if more specific information is available (e.g., \"Plexiform Neurofibroma\", \"Cutaneous Neurofibroma\"), that would be preferable.\n\nGiven the constraints and the information available, the above correction is made. \n\nThe final answer is:\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"next generation targeted sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2313,
            "outputTokens": 594,
            "totalTokens": 2907
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "46736530-aac8-4fea-93e2-ed6a2f62f29c",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:11 GMT",
                "content-type": "application/json",
                "content-length": "2887",
                "connection": "keep-alive",
                "x-amzn-requestid": "46736530-aac8-4fea-93e2-ed6a2f62f29c"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"Neurofibromatoses\". Looking at the Target Schema for \"diagnosis\", the closest and most specific term related to \"Neurofibromatoses\" is \"Neurofibromatosis type 1\". This is because \"Neurofibromatoses\" typically refers to a group of disorders that include Neurofibromatosis type 1, Neurofibromatosis type 2, and Schwannomatosis. Since \"Neurofibromatosis type 1\" is the most common condition associated with the term \"Neurofibromatoses\", we will use this as our corrected value.\n\n2. **Assay**: The input value is \"assay by high throughput sequencer\". The Target Schema for \"assay\" includes several sequencing-related terms. \"High throughput sequencer\" is commonly associated with \"next generation sequencing\" techniques. Among the options provided, \"whole exome sequencing\", \"whole genome sequencing\", and \"targeted sequencing\" are all forms of next-generation sequencing. However, without more specificity, the most general form that could be considered is \"next generation targeted sequencing\". This term is available in the enum list.\n\n3. **TumorType**: The input value is \"Nerve Sheath Neoplasm\". The Target Schema for \"tumorType\" includes several specific types of nerve sheath tumors. \"Nerve Sheath Neoplasm\" can refer to various types, including Schwannoma, Neurofibroma, and Malignant Peripheral Nerve Sheath Tumor. Among these, \"Neurofibroma\" and \"Schwannoma\" are directly listed. \"Malignant Peripheral Nerve Sheath Tumor\" is also listed. Without more specific information, we can choose one of these. \"Neurofibroma\" is a reasonable choice given its frequency and relevance.\n\nCorrected metadata:\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"next generation targeted sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nHowever, it's worth noting that \"next generation targeted sequencing\" is the chosen value for \"assay\" here because it's a specific term available in the enum. If the exact type of sequencing is known (e.g., whole exome, whole genome), that would be more appropriate. \n\nAlso, for \"tumorType\", if more specific information is available (e.g., \"Plexiform Neurofibroma\", \"Cutaneous Neurofibroma\"), that would be preferable.\n\nGiven the constraints and the information available, the above correction is made. \n\nThe final answer is:\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"next generation targeted sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2313,
              "outputTokens": 594,
              "totalTokens": 2907
            },
            "metrics": {
              "latencyMs": 2500
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2313,
          "output_tokens": 594,
          "total_tokens": 2907
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow down the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The term \"neurocutaneous syndrome\" is broad and encompasses several conditions. Looking at the enum values for \"diagnosis\" in the Target Schema, \"Neurofibromatosis type 1\" is a specific neurocutaneous syndrome. Therefore, if the context suggests that the neurocutaneous syndrome is specifically \"Neurofibromatosis type 1\", we can use that. Otherwise, we need to consider other options. Since \"Neurofibromatosis type 1\" is a specific condition under the broader category of neurocutaneous syndromes and is listed in the enum, we can use it if it's the intended diagnosis. However, without more context, it's a bit challenging. Other neurocutaneous syndromes are not directly listed, so we'll have to choose the closest or most relevant term available.\n\n2. **Assay**: The term \"spectroscopy\" is broad. The Target Schema includes several specific types of spectroscopy, such as \"FTIR spectroscopy\" and \"magnetic resonance spectroscopy\". Without more context on the type of spectroscopy, we can consider \"FTIR spectroscopy\" as a possible specific term if it's relevant to the context.\n\n3. **TumorType**: The value \"unknown\" is already present in the enum for \"tumorType\" in the Target Schema, so no change is needed here.\n\nGiven these considerations, let's correct the metadata. Assuming \"Neurofibromatosis type 1\" is the intended diagnosis and \"FTIR spectroscopy\" is a reasonable specification for \"spectroscopy\", the corrected metadata would be:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\nThis correction uses specific terms available in the Target Schema, maintaining the same structure as the input JSON. Note that the capitalization of \"Unknown\" for \"tumorType\" is adjusted to match the exact enum value (\"Unknown\") from the Target Schema.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2302,
            "outputTokens": 423,
            "totalTokens": 2725
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "03ed528b-ea5c-483b-8304-7454d067528b",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:13 GMT",
                "content-type": "application/json",
                "content-length": "2237",
                "connection": "keep-alive",
                "x-amzn-requestid": "03ed528b-ea5c-483b-8304-7454d067528b"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow down the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The term \"neurocutaneous syndrome\" is broad and encompasses several conditions. Looking at the enum values for \"diagnosis\" in the Target Schema, \"Neurofibromatosis type 1\" is a specific neurocutaneous syndrome. Therefore, if the context suggests that the neurocutaneous syndrome is specifically \"Neurofibromatosis type 1\", we can use that. Otherwise, we need to consider other options. Since \"Neurofibromatosis type 1\" is a specific condition under the broader category of neurocutaneous syndromes and is listed in the enum, we can use it if it's the intended diagnosis. However, without more context, it's a bit challenging. Other neurocutaneous syndromes are not directly listed, so we'll have to choose the closest or most relevant term available.\n\n2. **Assay**: The term \"spectroscopy\" is broad. The Target Schema includes several specific types of spectroscopy, such as \"FTIR spectroscopy\" and \"magnetic resonance spectroscopy\". Without more context on the type of spectroscopy, we can consider \"FTIR spectroscopy\" as a possible specific term if it's relevant to the context.\n\n3. **TumorType**: The value \"unknown\" is already present in the enum for \"tumorType\" in the Target Schema, so no change is needed here.\n\nGiven these considerations, let's correct the metadata. Assuming \"Neurofibromatosis type 1\" is the intended diagnosis and \"FTIR spectroscopy\" is a reasonable specification for \"spectroscopy\", the corrected metadata would be:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\nThis correction uses specific terms available in the Target Schema, maintaining the same structure as the input JSON. Note that the capitalization of \"Unknown\" for \"tumorType\" is adjusted to match the exact enum value (\"Unknown\") from the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2302,
              "outputTokens": 423,
              "totalTokens": 2725
            },
            "metrics": {
              "latencyMs": 2384
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2302,
          "output_tokens": 423,
          "total_tokens": 2725
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to examine each field and ensure that its value is either already precise or is replaced with a more specific term from the Target Schema.\n\n1. **diagnosis**: The value is \"Not Applicable\", which is an exact match in the controlled terminology for \"diagnosis\". So, no change is needed here.\n\n2. **assay**: The value is \"immunoassay\". Upon checking the Target Schema for \"assay\", we find that \"immunoassay\" is a valid enum value. Therefore, no correction is required for this field.\n\n3. **tumorType**: The value is \"neurofibroma\". Looking at the Target Schema for \"tumorType\", we see that \"Neurofibroma\" is a valid enum value. Note that the case should match exactly. So, we need to capitalize the first letter to make it \"Neurofibroma\".\n\nHere is the corrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis corrected metadata adheres to the Target Schema's controlled terminology for each field.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2304,
            "outputTokens": 242,
            "totalTokens": 2546
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "9fc20899-b2ee-4dcb-82c0-0d4d5594c26a",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:15 GMT",
                "content-type": "application/json",
                "content-length": "1279",
                "connection": "keep-alive",
                "x-amzn-requestid": "9fc20899-b2ee-4dcb-82c0-0d4d5594c26a"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to examine each field and ensure that its value is either already precise or is replaced with a more specific term from the Target Schema.\n\n1. **diagnosis**: The value is \"Not Applicable\", which is an exact match in the controlled terminology for \"diagnosis\". So, no change is needed here.\n\n2. **assay**: The value is \"immunoassay\". Upon checking the Target Schema for \"assay\", we find that \"immunoassay\" is a valid enum value. Therefore, no correction is required for this field.\n\n3. **tumorType**: The value is \"neurofibroma\". Looking at the Target Schema for \"tumorType\", we see that \"Neurofibroma\" is a valid enum value. Note that the case should match exactly. So, we need to capitalize the first letter to make it \"Neurofibroma\".\n\nHere is the corrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis corrected metadata adheres to the Target Schema's controlled terminology for each field."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2304,
              "outputTokens": 242,
              "totalTokens": 2546
            },
            "metrics": {
              "latencyMs": 1368
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2304,
          "output_tokens": 242,
          "total_tokens": 2546
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the input is \"neurofibromatosis\". The Target Schema provides several specific types of neurofibromatosis or related conditions. The most specific match available in the schema is \"Neurofibromatosis type 1\". Since \"neurofibromatosis\" is not further specified, we'll use \"Neurofibromatosis type 1\" as it is a common specific type.\n\n2. For the \"assay\" field, the input is \"plate based reporter assay\". The closest match in the Target Schema is \"massively parallel reporter assay\". However, \"plate based reporter assay\" is not exactly listed, and while it could be considered related to \"massively parallel reporter assay\", the exact term is not available. A more general term that could potentially fit is not directly available, so we need to look for the closest match or a term that could reasonably encompass it. Upon closer inspection, there isn't a direct match, but \"massively parallel reporter assay\" is the most specific type of reporter assay listed.\n\n3. For the \"tumorType\" field, the input is \"benign neurofibroma\". The Target Schema lists several types of neurofibroma. \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Plexiform Neurofibroma\", and \"Neurofibroma\" are all specific types of neurofibromas. \"Neurofibroma\" is the most direct match as it is listed in the schema, and it encompasses benign neurofibromas.\n\nCorrected metadata:\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction uses the exact controlled terminology values from the Target Schema where possible, narrowing broad synonyms to more specific terms.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2309,
            "outputTokens": 403,
            "totalTokens": 2712
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "1493aa16-ec8a-4155-86e3-f7c9b8f1b3cd",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:17 GMT",
                "content-type": "application/json",
                "content-length": "2070",
                "connection": "keep-alive",
                "x-amzn-requestid": "1493aa16-ec8a-4155-86e3-f7c9b8f1b3cd"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the input is \"neurofibromatosis\". The Target Schema provides several specific types of neurofibromatosis or related conditions. The most specific match available in the schema is \"Neurofibromatosis type 1\". Since \"neurofibromatosis\" is not further specified, we'll use \"Neurofibromatosis type 1\" as it is a common specific type.\n\n2. For the \"assay\" field, the input is \"plate based reporter assay\". The closest match in the Target Schema is \"massively parallel reporter assay\". However, \"plate based reporter assay\" is not exactly listed, and while it could be considered related to \"massively parallel reporter assay\", the exact term is not available. A more general term that could potentially fit is not directly available, so we need to look for the closest match or a term that could reasonably encompass it. Upon closer inspection, there isn't a direct match, but \"massively parallel reporter assay\" is the most specific type of reporter assay listed.\n\n3. For the \"tumorType\" field, the input is \"benign neurofibroma\". The Target Schema lists several types of neurofibroma. \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Plexiform Neurofibroma\", and \"Neurofibroma\" are all specific types of neurofibromas. \"Neurofibroma\" is the most direct match as it is listed in the schema, and it encompasses benign neurofibromas.\n\nCorrected metadata:\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction uses the exact controlled terminology values from the Target Schema where possible, narrowing broad synonyms to more specific terms."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2309,
              "outputTokens": 403,
              "totalTokens": 2712
            },
            "metrics": {
              "latencyMs": 2115
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2309,
          "output_tokens": 403,
          "total_tokens": 2712
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"RASopathy\". RASopathies are a group of genetic disorders caused by mutations in genes that encode components or regulators of the Ras/mitogen-activated protein kinase (MAPK) pathway. The specific diagnosis related to RASopathy in the given enum is \"Noonan Syndrome\". Therefore, we can narrow \"RASopathy\" to \"Noonan Syndrome\" as it is a specific condition within the broader category of RASopathies.\n\n2. **Assay**: The input value is \"immunoassay\". The Target Schema provides several specific types of immunoassays, but \"immunoassay\" itself is listed as a valid enum value. Therefore, no change is needed here as \"immunoassay\" is already a valid and specific term according to the schema.\n\n3. **TumorType**: The input value is \"NFIB\". \"NFIB\" is not directly listed in the enum for \"tumorType\". However, it can be related to \"Neurofibroma\" or other NF-related tumors. The closest and most relevant term in the enum is \"Neurofibroma\". Therefore, we can correct \"NFIB\" to \"Neurofibroma\".\n\nCorrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction adheres to the Target Schema by using the exact controlled terminology values provided.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2302,
            "outputTokens": 326,
            "totalTokens": 2628
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "c5bd8bc2-931f-4607-a541-cbb8b49430e2",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:19 GMT",
                "content-type": "application/json",
                "content-length": "1662",
                "connection": "keep-alive",
                "x-amzn-requestid": "c5bd8bc2-931f-4607-a541-cbb8b49430e2"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"RASopathy\". RASopathies are a group of genetic disorders caused by mutations in genes that encode components or regulators of the Ras/mitogen-activated protein kinase (MAPK) pathway. The specific diagnosis related to RASopathy in the given enum is \"Noonan Syndrome\". Therefore, we can narrow \"RASopathy\" to \"Noonan Syndrome\" as it is a specific condition within the broader category of RASopathies.\n\n2. **Assay**: The input value is \"immunoassay\". The Target Schema provides several specific types of immunoassays, but \"immunoassay\" itself is listed as a valid enum value. Therefore, no change is needed here as \"immunoassay\" is already a valid and specific term according to the schema.\n\n3. **TumorType**: The input value is \"NFIB\". \"NFIB\" is not directly listed in the enum for \"tumorType\". However, it can be related to \"Neurofibroma\" or other NF-related tumors. The closest and most relevant term in the enum is \"Neurofibroma\". Therefore, we can correct \"NFIB\" to \"Neurofibroma\".\n\nCorrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction adheres to the Target Schema by using the exact controlled terminology values provided."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2302,
              "outputTokens": 326,
              "totalTokens": 2628
            },
            "metrics": {
              "latencyMs": 1705
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2302,
          "output_tokens": 326,
          "total_tokens": 2628
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the value is \"NF\". \"NF\" is a broad term that could refer to Neurofibromatosis. The Target Schema provides specific types of Neurofibromatosis and related conditions. The most appropriate match for \"NF\" in this context could be \"Neurofibromatosis type 1\" as it is a specific and common condition associated with \"NF\".\n\n2. For the \"assay\" field, the value is \"medical imaging\". The Target Schema lists various specific medical imaging techniques. \"medical imaging\" is a broad term that encompasses many techniques. We need to choose a more specific term from the enum provided. Since \"medical imaging\" is broad, we can consider \"conventional MRI\", \"structural MRI\", or other specific imaging techniques listed. However, without more context, the most general specific term we can choose is \"conventional MRI\" as it is a common medical imaging technique.\n\n3. For the \"tumorType\" field, the value is \"unknown\". The Target Schema has \"Unknown\" as a valid enum value, which matches the given input.\n\nCorrecting the input data according to the Target Schema:\n\n- \"diagnosis\": \"NF\" -> \"Neurofibromatosis type 1\"\n- \"assay\": \"medical imaging\" -> \"conventional MRI\" (as a reasonable specific example, but note that the exact choice may depend on the context not provided)\n- \"tumorType\": \"unknown\" -> \"Unknown\"\n\nCorrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2299,
            "outputTokens": 373,
            "totalTokens": 2672
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "6609a9ae-4226-4d9b-86ef-5da094f4f110",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:21 GMT",
                "content-type": "application/json",
                "content-length": "1898",
                "connection": "keep-alive",
                "x-amzn-requestid": "6609a9ae-4226-4d9b-86ef-5da094f4f110"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the value is \"NF\". \"NF\" is a broad term that could refer to Neurofibromatosis. The Target Schema provides specific types of Neurofibromatosis and related conditions. The most appropriate match for \"NF\" in this context could be \"Neurofibromatosis type 1\" as it is a specific and common condition associated with \"NF\".\n\n2. For the \"assay\" field, the value is \"medical imaging\". The Target Schema lists various specific medical imaging techniques. \"medical imaging\" is a broad term that encompasses many techniques. We need to choose a more specific term from the enum provided. Since \"medical imaging\" is broad, we can consider \"conventional MRI\", \"structural MRI\", or other specific imaging techniques listed. However, without more context, the most general specific term we can choose is \"conventional MRI\" as it is a common medical imaging technique.\n\n3. For the \"tumorType\" field, the value is \"unknown\". The Target Schema has \"Unknown\" as a valid enum value, which matches the given input.\n\nCorrecting the input data according to the Target Schema:\n\n- \"diagnosis\": \"NF\" -> \"Neurofibromatosis type 1\"\n- \"assay\": \"medical imaging\" -> \"conventional MRI\" (as a reasonable specific example, but note that the exact choice may depend on the context not provided)\n- \"tumorType\": \"unknown\" -> \"Unknown\"\n\nCorrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```"
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2299,
              "outputTokens": 373,
              "totalTokens": 2672
            },
            "metrics": {
              "latencyMs": 2050
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2299,
          "output_tokens": 373,
          "total_tokens": 2672
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to replace the broad or non-specific terms with more precise terms as defined in the Target Schema.\n\n1. **Diagnosis**: The term \"neurocristopathy\" is broad and encompasses a range of conditions related to the abnormal development of cells derived from the neural crest. Looking at the provided enum values for \"diagnosis\", the closest and most specific term related to neural crest derivatives and relevant to the context would be \"Neurofibromatosis type 1\", as neurofibromas are derived from neural crest cells. However, \"neurocristopathy\" is not directly listed, and its direct mapping isn't straightforward without more context. Given the options, if the condition is related to NF1, it could be a suitable choice. Otherwise, \"Schwannomatosis\" or other specific conditions could be considered if more context is available. For the sake of this task, let's assume it's not directly mappable to the given enums without more specific information, so we'll consider \"Unknown\" as a potential fallback if a more specific diagnosis isn't available.\n\n2. **Assay**: The term \"transcriptomics\" is a broad field that encompasses several specific techniques for studying the transcriptome. The Target Schema includes \"RNA-seq\", \"lncRNA-seq\", \"miRNA-seq\", \"scRNA-seq\", \"single-cell RNA-seq\", and \"whole transcriptome sequencing\" under the \"assay\" enum, all of which are transcriptomics techniques. \"RNA-seq\" is a common and specific technique used in transcriptomics, making it a suitable choice for narrowing down \"transcriptomics\".\n\n3. **TumorType**: \"Neurolemmoma\" is an older term for \"Schwannoma\", which is a specific type of tumor. The enum for \"tumorType\" includes \"Schwannoma\", making it a direct and appropriate match.\n\nGiven these considerations, the corrected metadata would be:\n\n```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\nThis correction uses the exact controlled terminology values from the Target Schema, replacing broad or non-specific terms with more precise ones where possible.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2308,
            "outputTokens": 449,
            "totalTokens": 2757
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "9e11dace-1337-424b-853b-5931c80ded75",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:23 GMT",
                "content-type": "application/json",
                "content-length": "2352",
                "connection": "keep-alive",
                "x-amzn-requestid": "9e11dace-1337-424b-853b-5931c80ded75"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to replace the broad or non-specific terms with more precise terms as defined in the Target Schema.\n\n1. **Diagnosis**: The term \"neurocristopathy\" is broad and encompasses a range of conditions related to the abnormal development of cells derived from the neural crest. Looking at the provided enum values for \"diagnosis\", the closest and most specific term related to neural crest derivatives and relevant to the context would be \"Neurofibromatosis type 1\", as neurofibromas are derived from neural crest cells. However, \"neurocristopathy\" is not directly listed, and its direct mapping isn't straightforward without more context. Given the options, if the condition is related to NF1, it could be a suitable choice. Otherwise, \"Schwannomatosis\" or other specific conditions could be considered if more context is available. For the sake of this task, let's assume it's not directly mappable to the given enums without more specific information, so we'll consider \"Unknown\" as a potential fallback if a more specific diagnosis isn't available.\n\n2. **Assay**: The term \"transcriptomics\" is a broad field that encompasses several specific techniques for studying the transcriptome. The Target Schema includes \"RNA-seq\", \"lncRNA-seq\", \"miRNA-seq\", \"scRNA-seq\", \"single-cell RNA-seq\", and \"whole transcriptome sequencing\" under the \"assay\" enum, all of which are transcriptomics techniques. \"RNA-seq\" is a common and specific technique used in transcriptomics, making it a suitable choice for narrowing down \"transcriptomics\".\n\n3. **TumorType**: \"Neurolemmoma\" is an older term for \"Schwannoma\", which is a specific type of tumor. The enum for \"tumorType\" includes \"Schwannoma\", making it a direct and appropriate match.\n\nGiven these considerations, the corrected metadata would be:\n\n```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\nThis correction uses the exact controlled terminology values from the Target Schema, replacing broad or non-specific terms with more precise ones where possible."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2308,
              "outputTokens": 449,
              "totalTokens": 2757
            },
            "metrics": {
              "latencyMs": 2662
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2308,
          "output_tokens": 449,
          "total_tokens": 2757
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The term \"phakomatosis\" is broad and encompasses several conditions. Looking at the enum values for \"diagnosis\" in the Target Schema, we can see that \"Neurofibromatosis type 1\" is a specific condition that falls under the broader category of phakomatoses. Given that \"phakomatosis\" is not directly listed in the enum, we need to choose the most appropriate specific condition. \"Neurofibromatosis type 1\" is a plausible choice if the context is related to NF1. However, without more context, it's a bit challenging. Other options like \"Schwannomatosis\" could also be considered depending on the specific context. For the sake of this task, let's assume \"Neurofibromatosis type 1\" is the intended diagnosis.\n\n2. **Assay**: The term \"viability assay\" is broad. The Target Schema provides several specific types of viability assays. \"cell viability assay\" is a direct match and is listed in the enum for \"assay\".\n\n3. **TumorType**: \"tumor of cranial and spinal nerves\" is a broad term. Looking at the enum values for \"tumorType\", \"Schwannoma\" is a specific type of tumor that affects cranial and spinal nerves. It's a plausible choice if the context is related to schwannomas.\n\nGiven these considerations, the corrected metadata would be:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\nThis correction uses the exact controlled terminology values from the Target Schema, ensuring that the values match the specified enums.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2309,
            "outputTokens": 372,
            "totalTokens": 2681
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "89c6506e-dd7d-49c3-adf8-8ecbd0a517f8",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 04:53:25 GMT",
                "content-type": "application/json",
                "content-length": "1907",
                "connection": "keep-alive",
                "x-amzn-requestid": "89c6506e-dd7d-49c3-adf8-8ecbd0a517f8"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The term \"phakomatosis\" is broad and encompasses several conditions. Looking at the enum values for \"diagnosis\" in the Target Schema, we can see that \"Neurofibromatosis type 1\" is a specific condition that falls under the broader category of phakomatoses. Given that \"phakomatosis\" is not directly listed in the enum, we need to choose the most appropriate specific condition. \"Neurofibromatosis type 1\" is a plausible choice if the context is related to NF1. However, without more context, it's a bit challenging. Other options like \"Schwannomatosis\" could also be considered depending on the specific context. For the sake of this task, let's assume \"Neurofibromatosis type 1\" is the intended diagnosis.\n\n2. **Assay**: The term \"viability assay\" is broad. The Target Schema provides several specific types of viability assays. \"cell viability assay\" is a direct match and is listed in the enum for \"assay\".\n\n3. **TumorType**: \"tumor of cranial and spinal nerves\" is a broad term. Looking at the enum values for \"tumorType\", \"Schwannoma\" is a specific type of tumor that affects cranial and spinal nerves. It's a plausible choice if the context is related to schwannomas.\n\nGiven these considerations, the corrected metadata would be:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\nThis correction uses the exact controlled terminology values from the Target Schema, ensuring that the values match the specified enums."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2309,
              "outputTokens": 372,
              "totalTokens": 2681
            },
            "metrics": {
              "latencyMs": 1790
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2309,
          "output_tokens": 372,
          "total_tokens": 2681
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.4333333333333333,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 20.775326013565063,
    "token_usage": {
      "input_tokens": 23051,
      "output_tokens": 3931,
      "total_tokens": 26982
    }
  }
}